LifeVantage to Participate in the 2022 ICR Conference
SALT LAKE CITY, Jan. 10, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) announced that management will participate in the 2022 ICR Conference today, Monday, January 10th, at 9:30 a.m. Eastern Time.
SALT LAKE CITY, Jan. 10, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) announced that management will participate in the 2022 ICR Conference today, Monday, January 10th, at 9:30 a.m. Eastern Time.
The live webcast of the presentation will be accessible in News & Events section of the Company’s Investor Relations website at lifevantage.gcs-web.com. An archived replay of the webcast will also be available shortly after the live event has concluded.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath & body, and targeted relief products. The Company’s line of scientifically-validated dietary supplements includes its flagship Protandim® family of products, LifeVantage® Omega+, ProBio, and Daily Wellness dietary supplements, TrueScience® is the Company's line of skin, hair, bath & body, and targeted relief products. The Company also markets and sells Petandim®, its companion pet supplement formulated to combat oxidative stress in dogs, Axio® its nootropic energy drink mixes, and PhysIQ™, its smart weight management system. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
[email protected]
Media Relations Contact:
Jesse Allen
Senior VP of Marketing and Communications
(801) 432-9173
[email protected]
